Oculis Holding Ag (NASDAQ: OCS) reported Q4 2022 earnings per share (EPS) of -$3.20, up 47.99% year over year. Total Oculis Holding Ag earnings for the quarter were -$9.87 million. In the same quarter last year, Oculis Holding Ag's earnings per share (EPS) was -$2.17.
As of Q2 2023, Oculis Holding Ag's earnings has grown year over year. Oculis Holding Ag's earnings in the past year totalled -$42.53 million.
What was OCS's revenue last quarter?
Oculis Holding Ag (NASDAQ: OCS) reported Q4 2022 revenue of $230.11 thousand up 45.89% year over year. In the same quarter last year, Oculis Holding Ag's revenue was $425.27 thousand.
What was OCS's revenue growth in the past year?
As of Q2 2023, Oculis Holding Ag's revenue has grown -7.04% year over year. This is 76.82 percentage points lower than the US Biotechnology industry revenue growth rate of 69.78%. Oculis Holding Ag's revenue in the past year totalled $1.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.